HALOZYME THERAPEUTICS INC shareholders Q3 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FCF Advisors LLC 3,909$149,3240.08%
Ifrah Financial Services, Inc. 6,431$245,6550.08%
GLENMEDE TRUST CO NA 343,188$13,109,7810.08%
FRONTIER CAPITAL MANAGEMENT CO LLC 177,102$6,765,2960.07%
State of Wyoming 9,038$345,2520.07%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 155,422$5,937,1200.07%
NORDEN GROUP LLC 5,635$215,2570.07%
Lloyd Advisory Services, LLC. 5,635$215,2570.07%
Campbell & CO Investment Adviser LLC 15,465$590,7630.07%
USA FINANCIAL FORMULAS 1,226$46,8330.07%
EFG Asset Management (Americas) Corp. 7,682$293,4520.07%
UBS OCONNOR LLC 68,543$2,618,3430.07%
Ameritas Investment Partners, Inc. 42,357$1,618,0370.06%
AMERICAN INTERNATIONAL GROUP, INC. 249,560$9,533,1920.06%
Coastal Bridge Advisors, LLC 6,000$229,2000.06%
Allspring Global Investments Holdings, LLC 887,274$33,893,8980.06%
Verdence Capital Advisors LLC 14,434$551,3790.06%
Point72 Middle East FZE 45,399$1,734,2420.06%
NorthCrest Asset Manangement, LLC 36,824$1,406,6770.06%
GREAT LAKES ADVISORS, LLC 159,590$6,096,3380.06%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.